Pfizer Inc
NYSE: PFE
$24.80
-$1.22 (-4.7%)
Closing Price on November 15, 2024
PFE Articles
This morning we had four different DJIA components report earnings and so far all shares of these are indicated higher. AT&T (NYSE: T) posted $0.76 non-GAAP EPS vs. $0.76 estimates and generated...
Published:
Since 2006, 24/7 Wall St. has scrutinized public companies on a regular basis, focusing on those with poor management and has suggested which big company CEOs needed to be replaced. Hector Ruiz of...
Published:
Last Updated:
According to Reuters, Robert Steel was named the new CEO of Wachovia (WB) and the bank said it would have a quarter loss of $2.6 to $2.8 billion. Reuters writes that the Blue Chip Economic Indicators...
Published:
We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site. The study showed that a combination of fish oil and red rice yeast in...
Published:
If you thought this was a bad day for the market with the DJIA trading well under that 12,000 psychological level, there were some 400 stocks that hit 52-week lows today when you include the closed...
Published:
According to Reuters, Paulson will push for more market and financial regulations. Reuters writes the Anheuser-Busch (BUD) board will meet on the InBev offer. Reuters reports that the GAO was...
Published:
With the trading year almost half over and results from the first quarter out, 24/7 Wall St. has created the latest installment of its Ten Worst Managed Companies In America list. This analysis is...
Published:
One key stock to watch next week is Pfizer Inc. (NYSE: PFE). While it has been in the land of the boring forever, watchers are looking to see if it will put in a rival bid over the $4.6 Billion...
Published:
According to Reuters, Pfizer (PFE) may make a counter-bid for Ranbaxy Laboratories, the generic drug-maker. Reuters reports that deal talks between Yahoo! (YHOO) and Microsoft (MSFT) are dead. Yahoo!...
Published:
According to Reuters, Pfizer (PFE) may make a counter-bid for Ranbaxy Laboratories, the generic drug-maker. Reuters reports that deal talks between Yahoo! (YHOO) and Microsoft (MSFT) are dead. Yahoo!...
Published:
Webster Financial (WBS) Bank needs to raise cash. Falls to $21.77 from 52-week high of $46.40. Pfizer (PFE) Concerns about product pipeline. Sells down to $18.45 from 52-week high of $27.33. Nokia...
Published:
Wachovia (WB) Sacking of CEO is still driving away shareholders. Down to $21.04 from 52-week high of $54.54. Sun Microsystems (JAVA) sells off on concerns that the company’s bad forecasts could get...
Published:
According to Reuters, Yahoo! (YHOO) rejected a tie up with Google (GOOG) before the Microsoft (MSFT) bid. Retuers writes that loses may force Lehman (LEH) to raise another $3.4 billion. Reuters...
Published:
GM (GM) falls as sales appear to falter. Down to $16.87 from 52-week high of $43.20. The Colonial BancGroup (CNB) Worries about bank failures push shares down to $5.65 from 52-week high of $25.50....
Published:
It looks like Pfizer’s (PFE) anti-smoking drug Chantix makes people kick the habit but at the same time can push them toward suicide or depression. It is a hard decision whether patients want to...
Published: